Literature DB >> 28097372

The role of neuropeptides in adverse myocardial remodeling and heart failure.

Alexander Widiapradja1,2, Prasad Chunduri3, Scott P Levick4,5.   

Abstract

In addition to traditional neurotransmitters of the sympathetic and parasympathetic nervous systems, the heart also contains numerous neuropeptides. These neuropeptides not only modulate the effects of neurotransmitters, but also have independent effects on cardiac function. While in most cases the physiological actions of these neuropeptides are well defined, their contributions to cardiac pathology are less appreciated. Some neuropeptides are cardioprotective, some promote adverse cardiac remodeling and heart failure, and in the case of others their functions are unclear. Some have both cardioprotective and adverse effects depending on the specific cardiac pathology and progression of that pathology. In this review, we briefly describe the actions of several neuropeptides on normal cardiac physiology, before describing in more detail their role in adverse cardiac remodeling and heart failure. It is our goal to bring more focus toward understanding the contribution of neuropeptides to the pathogenesis of heart failure, and to consider them as potential therapeutic targets.

Entities:  

Keywords:  Cardiac remodeling; Cardiomegaly; Fibrosis; Hypertrophy

Mesh:

Substances:

Year:  2017        PMID: 28097372      PMCID: PMC6339818          DOI: 10.1007/s00018-017-2452-x

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  218 in total

1.  Involvement of the neurokinin-2 receptor in airway smooth muscle stretch-activated contractions assessed in perfused intact bovine bronchial segments.

Authors:  Jeremy Mark Hernandez; Gerard Cox; Luke Jeffrey Janssen
Journal:  J Pharmacol Exp Ther       Date:  2008-08-21       Impact factor: 4.030

2.  Induction of hypertrophic responsiveness of cardiomyocytes to neuropeptide Y in response to pressure overload.

Authors:  David Bell; Adrian R Allen; Elizabeth J Kelso; Ambikaipakan Balasubramaniam; Barbara J McDermott
Journal:  J Pharmacol Exp Ther       Date:  2002-11       Impact factor: 4.030

3.  Increased expression of the renin-angiotensin system and mast cell density but not of angiotensin-converting enzyme II in late stages of human heart failure.

Authors:  Montserrat Batlle; Eulàlia Roig; Fèlix Perez-Villa; Sergio Lario; Pilar Cejudo-Martin; Ester García-Pras; José Ortiz; Mercé Roqué; Josefina Orús; Montserrat Rigol; Magdalena Heras; José Ramírez; Wladimiro Jimenez
Journal:  J Heart Lung Transplant       Date:  2006-08-09       Impact factor: 10.247

4.  The influence of the neuropeptide galanin on the contractility and the effective refractory period of guinea-pig heart papillary muscle under normoxic and hypoxic conditions.

Authors:  I Kocic
Journal:  J Pharm Pharmacol       Date:  1998-12       Impact factor: 3.765

Review 5.  Cardio-vascular activity of catestatin: interlocking the puzzle pieces.

Authors:  R Mazza; B Tota; A Gattuso
Journal:  Curr Med Chem       Date:  2015       Impact factor: 4.530

6.  Calcitonin gene-related peptide suppresses isoprenaline-induced cardiomyocyte apoptosis through regulation of microRNA-1 and microRNA-133a expression.

Authors:  Jianzhe Li; Jun Peng; Chenjing Wang; Hanwu Deng; Yuanjian Li
Journal:  Zhong Nan Da Xue Xue Bao Yi Xue Ban       Date:  2011-10

7.  Non-human primate and rat cardiac fibroblasts show similar extracellular matrix-related and cellular adhesion gene responses to substance P.

Authors:  Giselle C Meléndez; Edward J Manteufel; Heather M Dehlin; Thomas C Register; Scott P Levick
Journal:  Heart Lung Circ       Date:  2014-12-05       Impact factor: 2.975

8.  Contractile effects of cardiac neuropeptides in isolated canine atrial and ventricular muscles.

Authors:  D F Rigel; I L Grupp; A Balasubramaniam; G Grupp
Journal:  Am J Physiol       Date:  1989-10

9.  C-terminal provasopressin (copeptin) is associated with left ventricular dysfunction, remodeling, and clinical heart failure in survivors of myocardial infarction.

Authors:  Dominic Kelly; Iain B Squire; Sohail Q Khan; Paulene Quinn; Joachim Struck; Nils G Morgenthaler; Joan E Davies; Leong L Ng
Journal:  J Card Fail       Date:  2008-08-30       Impact factor: 5.712

10.  Plasma proneurotensin and incidence of diabetes, cardiovascular disease, breast cancer, and mortality.

Authors:  Olle Melander; Alan S Maisel; Peter Almgren; Jonas Manjer; Mattias Belting; Bo Hedblad; Gunnar Engström; Ute Kilger; Peter Nilsson; Andreas Bergmann; Marju Orho-Melander
Journal:  JAMA       Date:  2012-10-10       Impact factor: 56.272

View more
  8 in total

Review 1.  Mechanistic Biomarkers Informative of Both Cancer and Cardiovascular Disease: JACC State-of-the-Art Review.

Authors:  Vivek Narayan; Elizabeth W Thompson; Biniyam Demissei; Jennifer E Ho; James L Januzzi; Bonnie Ky
Journal:  J Am Coll Cardiol       Date:  2020-06-02       Impact factor: 24.094

2.  Substance P-mediated cardiac mast cell activation: An in vitro study.

Authors:  Scott P Levick; Gregory L Brower; Joseph S Janicki
Journal:  Neuropeptides       Date:  2019-01-08       Impact factor: 3.286

Review 3.  Neuropeptide signalling systems - An underexplored target for venom drug discovery.

Authors:  Helen C Mendel; Quentin Kaas; Markus Muttenthaler
Journal:  Biochem Pharmacol       Date:  2020-06-30       Impact factor: 5.858

4.  Exploration of Mechanisms of Sacubitril/Valsartan in the Treatment of Cardiac Arrhythmias Using a Network Pharmacology Approach.

Authors:  Yu Zhou; Shibao Rui; Shengxin Tang; Changlin Ju
Journal:  Front Cardiovasc Med       Date:  2022-04-13

5.  Dissecting the cellular landscape and transcriptome network in viral myocarditis by single-cell RNA sequencing.

Authors:  Ninaad Lasrado; Nicholas Borcherding; Rajkumar Arumugam; Timothy K Starr; Jay Reddy
Journal:  iScience       Date:  2022-02-02

6.  Saxagliptin Cardiotoxicity in Chronic Heart Failure: The Role of DPP4 in the Regulation of Neuropeptide Tone.

Authors:  Imre Vörös; Zsófia Onódi; Viktória Éva Tóth; Tamás G Gergely; Éva Sághy; Anikó Görbe; Ágnes Kemény; Przemyslaw Leszek; Zsuzsanna Helyes; Péter Ferdinandy; Zoltán V Varga
Journal:  Biomedicines       Date:  2022-07-01

Review 7.  The Role of Neuropeptide Y in Cardiovascular Health and Disease.

Authors:  Cheryl M J Tan; Peregrine Green; Nidi Tapoulal; Adam J Lewandowski; Paul Leeson; Neil Herring
Journal:  Front Physiol       Date:  2018-09-19       Impact factor: 4.566

Review 8.  Catestatin as a Biomarker of Cardiovascular Diseases: A Clinical Perspective.

Authors:  Josko Bozic; Marko Kumric; Tina Ticinovic Kurir; Hrvoje Urlic; Dinko Martinovic; Marino Vilovic; Nada Tomasovic Mrcela; Josip A Borovac
Journal:  Biomedicines       Date:  2021-11-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.